Lemonade (LMND) director receives stock grants, boosting holdings

Rhea-AI Filing Summary

Angelidis-Smith Maria reported acquisition or exercise transactions in this Form 4 filing.

Lemonade, Inc. director Maria Angelidis-Smith reported stock awards rather than market purchases. On March 10, 2026, she received 3,350 shares of common stock directly at $55.30 per share, bringing her direct holdings to 14,896 shares. On the same date, 5,390 shares at $55.70 per share were awarded to the Smith Family Trust, where she is co-trustee with voting and dispositive control, increasing those indirect holdings to 38,944 shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Angelidis-Smith Maria

Role Director

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK	3,350	$55.30	$185K
Grant/Award	COMMON STOCK	5,390	$55.70	$300K

Holdings After Transaction: COMMON STOCK — 14,896 shares (Direct); COMMON STOCK — 38,944 shares (Indirect, Held by Smith Family Trust)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Angelidis-Smith Maria

(Last) (First) (Middle)

5 CROSBY STREET

3RD FLOOR

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lemonade, Inc. [ LMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	03/10/2026		A		3,350	A	$55.3	14,896	D
COMMON STOCK	03/10/2026		A		5,390	A	$55.7	38,944	I(1)	Held by Smith Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person is Co-Trustee of Smith Family Trust dated November 9, 2013 ("Trust") and has voting and dispositive control over the shares held by Trust.

Remarks:

	/s/ Timothy Bixby, Attorney-in-Fact for Maria Angelidis-Smith	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LMND director Maria Angelidis-Smith report?

Maria Angelidis-Smith reported stock awards of Lemonade common shares, not open-market trades. She received 3,350 shares directly and 5,390 shares indirectly through the Smith Family Trust as compensation-type grants on March 10, 2026, increasing both direct and trust holdings.

Were the LMND insider transactions open-market buys or stock awards?

The LMND insider transactions were stock awards, coded as grants. Both entries use transaction code A, indicating compensation-related acquisitions rather than open-market purchases, with specified grant prices of $55.30 and $55.70 per share on March 10, 2026.

How many Lemonade (LMND) shares does Maria Angelidis-Smith hold after these grants?

After these grants, Maria Angelidis-Smith holds 14,896 Lemonade shares directly. Indirectly, the Smith Family Trust, where she serves as co-trustee with voting and dispositive control, holds 38,944 shares, according to the reported post-transaction balances in the filing.

What role does the Smith Family Trust play in the LMND Form 4 filing?

The Smith Family Trust received 5,390 Lemonade shares in an award. A footnote explains Angelidis-Smith is co-trustee and has voting and dispositive control over shares held by the trust, so these are reported as indirect holdings associated with her position.

Does the LMND Form 4 show any insider sales or dispositions?

The LMND Form 4 shows no insider sales or share dispositions. Both reported transactions are coded as A, meaning grants or awards, and the transaction summary indicates only acquisitions, with zero sell, gift, tax-withholding, or restructuring entries reported.

Are there any derivative securities or options reported for LMND in this Form 4?

This Form 4 reports only non-derivative Lemonade common stock transactions. The derivative summary section is empty, indicating no new option, warrant, or other derivative exercises or positions were reported in connection with these stock awards.